Correlation Between Neoleukin Therapeutics and NextCure
Can any of the company-specific risk be diversified away by investing in both Neoleukin Therapeutics and NextCure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neoleukin Therapeutics and NextCure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neoleukin Therapeutics and NextCure, you can compare the effects of market volatilities on Neoleukin Therapeutics and NextCure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neoleukin Therapeutics with a short position of NextCure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neoleukin Therapeutics and NextCure.
Diversification Opportunities for Neoleukin Therapeutics and NextCure
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Neoleukin and NextCure is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Neoleukin Therapeutics and NextCure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCure and Neoleukin Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neoleukin Therapeutics are associated (or correlated) with NextCure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCure has no effect on the direction of Neoleukin Therapeutics i.e., Neoleukin Therapeutics and NextCure go up and down completely randomly.
Pair Corralation between Neoleukin Therapeutics and NextCure
If you would invest 69.00 in Neoleukin Therapeutics on August 26, 2024 and sell it today you would earn a total of 0.00 from holding Neoleukin Therapeutics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 1.54% |
| Values | Daily Returns |
Neoleukin Therapeutics vs. NextCure
Performance |
| Timeline |
| Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| NextCure |
Neoleukin Therapeutics and NextCure Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neoleukin Therapeutics and NextCure
The main advantage of trading using opposite Neoleukin Therapeutics and NextCure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neoleukin Therapeutics position performs unexpectedly, NextCure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCure will offset losses from the drop in NextCure's long position.| Neoleukin Therapeutics vs. CytomX Therapeutics | Neoleukin Therapeutics vs. Spero Therapeutics | Neoleukin Therapeutics vs. Instil Bio | Neoleukin Therapeutics vs. NextCure |
| NextCure vs. CytomX Therapeutics | NextCure vs. Spero Therapeutics | NextCure vs. Instil Bio | NextCure vs. Assembly Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |